These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35337046)

  • 21. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation.
    Lee BU
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosol and bioaerosol particle size and dynamics from defective sanitary plumbing systems.
    Gormley M; Aspray TJ; Kelly DA
    Indoor Air; 2021 Sep; 31(5):1427-1440. PubMed ID: 33569864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of E-Liquid Humectants, Nicotine, and Flavorings on Aerosol Particle Size Distribution and Implications for Modeling Respiratory Deposition.
    Stefaniak AB; Ranpara AC; Virji MA; LeBouf RF
    Front Public Health; 2022; 10():782068. PubMed ID: 35372219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro comparison of surgical techniques in times of the SARS-CoV-2 pandemic: electrocautery generates more droplets and aerosol than laser surgery or drilling.
    Guderian DB; Loth AG; Weiß R; Diensthuber M; Stöver T; Leinung M
    Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1237-1245. PubMed ID: 32895799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities.
    Ong SWX; Tan YK; Coleman KK; Tan BH; Leo YS; Wang DL; Ng CG; Ng OT; Wong MSY; Marimuthu K
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1327-1332. PubMed ID: 33487210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma.
    Mitchell DM; Solomon MA; Tolfree SE; Short M; Spiro SG
    Thorax; 1987 Jun; 42(6):457-61. PubMed ID: 3660305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.
    Dennis JH; Stenton SC; Beach JR; Avery AJ; Walters EH; Hendrick DJ
    Thorax; 1990 Oct; 45(10):728-32. PubMed ID: 2247862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.
    Subat YW; Hainy ME; Torgerud KD; Sajgalik P; Guntupalli SK; Johnson BD; Chul-Ho K; Lim KG; Helgeson SA; Scanlon PD; Niven AS
    Respir Care; 2021 Dec; 66(12):1858-1865. PubMed ID: 34789516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
    Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
    Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Large Mobile Air Purifiers on Aerosol Concentration in Classrooms and the Reduction of Airborne Transmission of SARS-CoV-2.
    Duill FF; Schulz F; Jain A; Krieger L; van Wachem B; Beyrau F
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic.
    Lavorini F; Usmani OS; Dhand R
    Intern Emerg Med; 2021 Nov; 16(8):2035-2039. PubMed ID: 34331192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments.
    Groma V; Kugler S; Farkas Á; Füri P; Madas B; Nagy A; Erdélyi T; Horváth A; Müller V; Szántó-Egész R; Micsinai A; Gálffy G; Osán J
    Sci Rep; 2023 Mar; 13(1):3566. PubMed ID: 36864124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Size distribution and speciation of chromium in paint spray aerosol at an aerospace facility.
    Sabty-Daily RA; Harris PA; Hinds WC; Froines JR
    Ann Occup Hyg; 2005 Jan; 49(1):47-59. PubMed ID: 15591325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Size distribution of exhaled aerosol particles containing SARS-CoV-2 RNA.
    Alsved M; Nygren D; Thuresson S; Fraenkel CJ; Medstrand P; Löndahl J
    Infect Dis (Lond); 2023 Feb; 55(2):158-163. PubMed ID: 36331347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.
    Berg E; Lamb P; Ali A; Dennis J; Tservistas M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):21-5. PubMed ID: 18430403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of disposable transport ventilators with combination aerosol therapy.
    Mac Giolla Eain M; O'Sullivan A; Joyce M; MacLoughlin R
    BMJ Open Respir Res; 2021 Mar; 8(1):. PubMed ID: 33771812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
    Asmus MJ; Milavetz G; Tice AL; Teresi ME
    Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator.
    Biddiscombe MF; Barnes PJ; Usmani OS
    J Aerosol Med; 2006; 19(3):245-53. PubMed ID: 17034300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols.
    Mitchell JP; Nagel MW
    J Aerosol Med; 1999; 12(4):217-40. PubMed ID: 10724637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.